S&P 500   4,270.96 (-0.07%)
DOW   33,876.15 (-0.31%)
QQQ   329.08 (+0.18%)
AAPL   174.07 (-0.27%)
MSFT   290.50 (-0.28%)
META   174.52 (-0.19%)
GOOGL   119.96 (+0.34%)
AMZN   142.02 (-0.06%)
TSLA   912.37 (+0.04%)
NVDA   187.11 (+2.05%)
NIO   19.90 (-0.90%)
BABA   90.49 (+0.80%)
AMD   100.38 (+2.15%)
MU   62.84 (+1.98%)
T   18.42 (+0.00%)
CGC   3.80 (-6.40%)
F   16.00 (-0.19%)
GE   79.31 (-0.76%)
DIS   122.31 (-0.41%)
AMC   20.12 (-5.81%)
PYPL   98.63 (-0.79%)
PFE   48.57 (-1.42%)
NFLX   245.04 (+1.61%)
S&P 500   4,270.96 (-0.07%)
DOW   33,876.15 (-0.31%)
QQQ   329.08 (+0.18%)
AAPL   174.07 (-0.27%)
MSFT   290.50 (-0.28%)
META   174.52 (-0.19%)
GOOGL   119.96 (+0.34%)
AMZN   142.02 (-0.06%)
TSLA   912.37 (+0.04%)
NVDA   187.11 (+2.05%)
NIO   19.90 (-0.90%)
BABA   90.49 (+0.80%)
AMD   100.38 (+2.15%)
MU   62.84 (+1.98%)
T   18.42 (+0.00%)
CGC   3.80 (-6.40%)
F   16.00 (-0.19%)
GE   79.31 (-0.76%)
DIS   122.31 (-0.41%)
AMC   20.12 (-5.81%)
PYPL   98.63 (-0.79%)
PFE   48.57 (-1.42%)
NFLX   245.04 (+1.61%)
S&P 500   4,270.96 (-0.07%)
DOW   33,876.15 (-0.31%)
QQQ   329.08 (+0.18%)
AAPL   174.07 (-0.27%)
MSFT   290.50 (-0.28%)
META   174.52 (-0.19%)
GOOGL   119.96 (+0.34%)
AMZN   142.02 (-0.06%)
TSLA   912.37 (+0.04%)
NVDA   187.11 (+2.05%)
NIO   19.90 (-0.90%)
BABA   90.49 (+0.80%)
AMD   100.38 (+2.15%)
MU   62.84 (+1.98%)
T   18.42 (+0.00%)
CGC   3.80 (-6.40%)
F   16.00 (-0.19%)
GE   79.31 (-0.76%)
DIS   122.31 (-0.41%)
AMC   20.12 (-5.81%)
PYPL   98.63 (-0.79%)
PFE   48.57 (-1.42%)
NFLX   245.04 (+1.61%)
S&P 500   4,270.96 (-0.07%)
DOW   33,876.15 (-0.31%)
QQQ   329.08 (+0.18%)
AAPL   174.07 (-0.27%)
MSFT   290.50 (-0.28%)
META   174.52 (-0.19%)
GOOGL   119.96 (+0.34%)
AMZN   142.02 (-0.06%)
TSLA   912.37 (+0.04%)
NVDA   187.11 (+2.05%)
NIO   19.90 (-0.90%)
BABA   90.49 (+0.80%)
AMD   100.38 (+2.15%)
MU   62.84 (+1.98%)
T   18.42 (+0.00%)
CGC   3.80 (-6.40%)
F   16.00 (-0.19%)
GE   79.31 (-0.76%)
DIS   122.31 (-0.41%)
AMC   20.12 (-5.81%)
PYPL   98.63 (-0.79%)
PFE   48.57 (-1.42%)
NFLX   245.04 (+1.61%)
NYSE:STE

STERIS - STE Stock Forecast, Price & News

$211.36
-0.27 (-0.13%)
(As of 08/18/2022 12:34 PM ET)
Add
Compare
Today's Range
$210.93
$212.93
50-Day Range
$192.78
$225.65
52-Week Range
$192.40
$255.93
Volume
6,423 shs
Average Volume
469,216 shs
Market Capitalization
$21.14 billion
P/E Ratio
56.66
Dividend Yield
0.81%
Price Target
$252.00

STERIS MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
19.2% Upside
$252.00 Price Target
Short Interest
Healthy
1.44% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.27mentions of STERIS in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$545,919 Sold Last Quarter
Proj. Earnings Growth
14.45%
From $8.51 to $9.74 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.95 out of 5 stars

Medical Sector

34th out of 1,122 stocks

Surgical Appliances & Supplies Industry

4th out of 23 stocks

STE stock logo

About STERIS (NYSE:STE) Stock

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STERIS Trading Down 0.4 %

Shares of NYSE:STE traded down $0.84 during midday trading on Wednesday, hitting $211.63. 267,039 shares of the company traded hands, compared to its average volume of 488,112. STERIS has a 12-month low of $192.40 and a 12-month high of $255.93. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.35 and a current ratio of 2.03. The stock has a 50-day moving average price of $210.31 and a 200 day moving average price of $224.55. The firm has a market cap of $21.17 billion, a P/E ratio of 56.74 and a beta of 0.71.

STERIS Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 23rd. Stockholders of record on Wednesday, September 7th will be issued a dividend of $0.47 per share. This is a boost from STERIS's previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, September 6th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.89%. STERIS's dividend payout ratio is presently 46.11%.

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. KeyCorp decreased their price objective on shares of STERIS from $256.00 to $240.00 and set an "overweight" rating on the stock in a research report on Thursday, August 4th. JMP Securities reduced their price target on shares of STERIS from $270.00 to $250.00 in a research report on Thursday, August 4th. TheStreet upgraded shares of STERIS from a "c+" rating to a "b" rating in a research report on Tuesday, August 2nd. StockNews.com raised STERIS from a "hold" rating to a "buy" rating in a research note on Thursday, August 11th. Finally, Piper Sandler initiated coverage on STERIS in a research note on Thursday, July 14th. They set an "overweight" rating and a $240.00 price objective for the company. Seven equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has a consensus rating of "Buy" and an average target price of $252.00.

Insider Activity

In related news, VP John Adam Zangerle sold 2,659 shares of the stock in a transaction that occurred on Wednesday, June 15th. The shares were sold at an average price of $205.31, for a total transaction of $545,919.29. Following the transaction, the vice president now owns 27,936 shares in the company, valued at $5,735,540.16. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.95% of the company's stock.

Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Stock News Headlines

STERIS (NYSE:STE) Raised to "Buy" at StockNews.com
STERIS (NYSE:STE) Rating Lowered to Hold at StockNews.com
STERIS (NYSE:STE) Price Target Cut to $250.00
Q2 2023 EPS Estimates for STERIS plc Cut by KeyCorp (NYSE:STE)
Expert Ratings for Steris
STERIS (NYSE:STE) Raised to "B" at TheStreet
Steris FQ1 2023 Earnings Preview - Seeking Alpha
STERIS Raises Dividend to $0.47 per share
See More Headlines
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

STE Company Calendar

Last Earnings
11/02/2021
Ex-Dividend for 6/28 Dividend
6/13/2022
Dividend Payable
6/28/2022
Today
8/18/2022
Ex-Dividend for 9/23 Dividend
9/06/2022
Dividend Payable
9/23/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
85915210
Employees
16,422
Year Founded
1987

Price Target and Rating

Average Stock Price Forecast
$252.00
High Stock Price Forecast
$275.00
Low Stock Price Forecast
$237.00
Forecasted Upside/Downside
+19.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$243.89 million
Pretax Margin
10.02%

Debt

Sales & Book Value

Annual Sales
$4.59 billion
Cash Flow
$13.90 per share
Book Value
$64.18 per share

Miscellaneous

Free Float
99,065,000
Market Cap
$21.14 billion
Optionable
Optionable
Beta
0.71

Social Links















STE Stock - Frequently Asked Questions

Should I buy or sell STERIS stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" STE shares.
View STE analyst ratings
or view top-rated stocks.

What is STERIS's stock price forecast for 2022?

6 Wall Street research analysts have issued 12 month price objectives for STERIS's shares. Their STE share price forecasts range from $237.00 to $275.00. On average, they anticipate the company's share price to reach $252.00 in the next year. This suggests a possible upside of 19.1% from the stock's current price.
View analysts price targets for STE
or view top-rated stocks among Wall Street analysts.

How have STE shares performed in 2022?

STERIS's stock was trading at $243.41 at the beginning of 2022. Since then, STE shares have decreased by 13.1% and is now trading at $211.63.
View the best growth stocks for 2022 here
.

When is STERIS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our STE earnings forecast
.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) released its quarterly earnings results on Tuesday, November, 2nd. The medical equipment provider reported $1.99 earnings per share for the quarter, beating analysts' consensus estimates of $1.82 by $0.17. The medical equipment provider had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.16 billion. STERIS had a trailing twelve-month return on equity of 12.40% and a net margin of 7.90%. During the same quarter last year, the firm posted $1.48 EPS.
Read the conference call transcript
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS announced a quarterly dividend on Thursday, July 28th. Investors of record on Wednesday, September 7th will be given a dividend of $0.47 per share on Friday, September 23rd. This represents a $1.88 annualized dividend and a dividend yield of 0.89%. The ex-dividend date of this dividend is Tuesday, September 6th. This is a boost from the stock's previous quarterly dividend of $0.43.
Read our dividend analysis for STE
.

Is STERIS a good dividend stock?

STERIS (NYSE:STE) pays an annual dividend of $1.72 per share and currently has a dividend yield of 0.81%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 46.11%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STE will have a dividend payout ratio of 17.66% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for STE.

What guidance has STERIS issued on next quarter's earnings?

STERIS updated its FY 2023 earnings guidance on Tuesday, August, 9th. The company provided earnings per share guidance of $8.40-$8.60 for the period, compared to the consensus estimate of $8.70. The company issued revenue guidance of $5.00 billion-$5.00 billion, compared to the consensus revenue estimate of $5.12 billion.

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are STERIS's major shareholders?

STERIS's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include WCM Investment Management LLC (6.10%), Massachusetts Financial Services Co. MA (4.60%), State Street Corp (4.24%), Price T Rowe Associates Inc. MD (2.39%), Pictet Asset Management SA (1.69%) and Northern Trust Corp (1.31%). Insiders that own company stock include Cary L Majors, Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends
.

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $211.63.

How much money does STERIS make?

STERIS (NYSE:STE) has a market capitalization of $21.17 billion and generates $4.59 billion in revenue each year. The medical equipment provider earns $243.89 million in net income (profit) each year or $3.73 on an earnings per share basis.

How many employees does STERIS have?

The company employs 16,422 workers across the globe.

When was STERIS founded?

STERIS was founded in 1987.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The official website for the company is www.steris.com. The medical equipment provider can be reached via phone at (531) 232-2000, via email at julie_winter@steris.com, or via fax at 440-639-4457.

This page (NYSE:STE) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.